IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients (MBC)
This study has been withdrawn prior to enrollment.
(changing indication from breast cancer to metastatic colorectal cancer)
Sponsor:
Immunovative Therapies, Ltd.
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.
ClinicalTrials.gov Identifier:
NCT02018419
First received: December 17, 2013
Last updated: April 1, 2015
Last verified: April 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | March 2017 |
| Estimated Primary Completion Date: | March 2016 (Final data collection date for primary outcome measure) |
Publications: